The nation of Zimbabwe has turned down a major US health deal worth $367m (272 million pounds) over five years because of the United States' demand for confidential biological samples.
The decision became public following a official document from December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesman has since explained that the US was demanding access to biological samples for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from any future vaccines.
"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for more negotiations to secure a agreement agreeable to both sides so the nation's critical HIV programme can proceed.
Wider Context
This rejection comes after a similar case in Kenya, where a court halted a related deal with the US after concerns were filed about the security of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
According to statements, 16 nations in Africa have so far agreed to similar agreements, representing over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered immense advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment via US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"Put simply, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be available to our population if a new pandemic emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting frameworks already established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with potential global health emergencies.
"This framework is designed to guarantee that when a nation provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how future co-operation might be designed in a manner that honours the independence and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that negotiations must proceed given that much of the nation's HIV programmes were funded by foreign aid.
"If specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," the group said.
This impasse highlights the complex debate between receiving crucial foreign assistance and safeguarding national sovereignty in an ever more interconnected world.